Occurrence of variants with temperature-dependent susceptibility (TDS) to antibiotics among Stenotrophomonas maltophilia clinical strains
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
11501404
DOI
10.1007/bf02873595
Knihovny.cz E-zdroje
- MeSH
- antibakteriální látky farmakologie MeSH
- bakteriální léková rezistence MeSH
- genetická variace * MeSH
- mikrobiální testy citlivosti MeSH
- Stenotrophomonas maltophilia účinky léků MeSH
- teplota MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- antibakteriální látky MeSH
Susceptibility to 20 antibiotics was tested in 104 Stenotrophomonas maltophilia strains at 37 and 30 degrees C by means of a dilution micromethod to verify the phenomenon of temperature-dependent susceptibility (TDS). Trimethoprim-sulfamethoxazole, pefloxacin and ofloxacin were the most active preparations at 37 degrees C (93, 90, and 86% of susceptible strains, respectively), whilst trimethoprim-sulfamethoxazole, cefoperazone-sulbactam and pefloxacin performed best at 30 degrees C (94, 94, and 76% of susceptible strains, respectively). Variants 37TDS (minimum inhibitory concentration, MIC, of tested antibiotics at least 4-times lower at 37 than at 30 degrees C) occurred in 60%. Variants 30TDS (at least 4-times lower value of MIC at 30 than at 37 degrees C) were found in 7.7%. Both variants in susceptibility to tested antibiotics appeared in 23.1%, whilst neither of them was observed in 9.6%. The 37TDS phenomenon was recorded most of all with gentamicin (51% of strains), amikacin (47), colistin (44) and tetracycline (34). The 30TDS phenomenon was found particularly with cefoperazone-sulbactam (16.0% of strains) and colistin (10.0%). The above phenomena may be due to changes in membrane permeability, temperature-dependent ribosomal changes, and insufficient adaptation to higher temperatures of some strains of the originally environmental species S. maltophilia.
Zobrazit více v PubMed
Pathology. 1994 Jul;26(3):321-4 PubMed
Diagn Microbiol Infect Dis. 1991 May-Jun;14(3):239-43 PubMed
Rev Infect Dis. 1990 Nov-Dec;12(6):997-1003 PubMed
Antimicrob Agents Chemother. 1994 Mar;38(3):624-7 PubMed
Antimicrob Agents Chemother. 1996 Jun;40(6):1412-8 PubMed
J Clin Pathol. 1985 Sep;38(9):1055-8 PubMed
Zentralbl Bakteriol. 1997 Jan;285(2):299-304 PubMed
Infect Control Hosp Epidemiol. 1990 Mar;11(3):134-8 PubMed
Antimicrob Agents Chemother. 1990 Nov;34(11):2256-9 PubMed
Diagn Microbiol Infect Dis. 1991 Sep-Oct;14(5):447-50 PubMed
J Med Microbiol. 1991 Oct;35(4):208-13 PubMed
J Antimicrob Chemother. 1997 Jul;40(1):13-7 PubMed
J Antimicrob Chemother. 1995 Aug;36(2):317-26 PubMed
APMIS. 1996 Feb;104(2):108-14 PubMed
Antimicrob Agents Chemother. 1994 Oct;38(10):2317-22 PubMed
J Antimicrob Chemother. 1997 Jan;39(1):19-24 PubMed
J Gen Microbiol. 1986 Jul;132(7):1827-42 PubMed
Antibiotic resistance of Stenotrophomonas maltophilia strains isolated from captive snakes
